It has been proposed that strategies that involve primary vaccinations with DNA followed by boosting with a recombinant poxvirus vector encoding the same immunogen, could elicit a protective CD8+ T cell response in animal models against various diseases such as HIV, malaria, and even cancer (35). The gene discussed is CD8A; the disease is malaria.